Show simple item record

dc.contributor.advisorFeitelson, Mark
dc.creatorYuan, Ke
dc.date.accessioned2020-11-05T16:15:53Z
dc.date.available2020-11-05T16:15:53Z
dc.date.issued2011
dc.identifier.other864885229
dc.identifier.urihttp://hdl.handle.net/20.500.12613/3905
dc.description.abstractChronic Hepatitis B Virus (HBV) infection is a global health problem because of its connection to acute and chronic liver diseases as well as hepatocellular carcinoma (HCC). There is increasing evidence showing that HBV contributes to HCC due to persistently high levels of trans-activating protein---hepatitis B encoded x antigen (HBxAg). Studies have shown that the HBxAg affects and alters the activity of many different transcription factors and plays an essential role in several cytoplasmic signaling transduction pathways, such as Wnt signaling pathways. One of the upregulated genes, designated URG11, was found transactivated by HBxAg. URG11 could stimulate the ß-catenin promoter and hepatocellular growth and survival which suggest that URG11 may be a regulatory element in the ß-catenin signaling pathways. microRNA148a (miR148a) was identified from two miRNA microarrays as one of the up-regulated miRNAs in cells stably expressing HBxAg or over-expressing URG11. Moreover, the expression of miR148a was also elevated in HBV-mediated HCC patient tissue samples. To study the function of miR148a, HepG2 (hepatoblastoma) and Hep3B (hepatoma) cells stably expressing HBxAg or over-expressing URG11 were transduced by recombinant lentiviruses encoding anti-miR148a. anti-miR148a suppressed cell proliferation, cell cycle progression, cell migration, anchorage independent growth in soft agar and subcutaneous tumor formation in SCID mice. Further, introduction of anti-miR148a increased PTEN protein and mRNA expression, suggesting that PTEN was suppressed by miR148a. In addition, anti-miR148a blocked the stimulation of Akt signaling, resulting in decreased expression of ß-catenin. Thus, miR148a may play a central role in HBxAg/URG11 mediated HCC, and may be an early diagnostic marker and/or therapeutic target associated with this tumor type.
dc.format.extent118 pages
dc.language.isoeng
dc.publisherTemple University. Libraries
dc.relation.ispartofTheses and Dissertations
dc.rightsIN COPYRIGHT- This Rights Statement can be used for an Item that is in copyright. Using this statement implies that the organization making this Item available has determined that the Item is in copyright and either is the rights-holder, has obtained permission from the rights-holder(s) to make their Work(s) available, or makes the Item available under an exception or limitation to copyright (including Fair Use) that entitles it to make the Item available.
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectVirology
dc.subjectBiochemistry
dc.subjectCellular Biology
dc.subjectAkt
dc.subjectHepatitis B X Antigen
dc.subjectHepatocellular Carcinoma
dc.subjectMir148a
dc.subjectPten
dc.subjectUrg11
dc.titleTHE CHARACTERIZATION OF HSA-MIR148A IN HEPATOCARCINOGENESIS
dc.typeText
dc.type.genreThesis/Dissertation
dc.contributor.committeememberWaring, Richard B.
dc.contributor.committeememberBiemar, Frederic
dc.contributor.committeememberRamirez, Servio H.
dc.description.departmentBiology
dc.relation.doihttp://dx.doi.org/10.34944/dspace/3887
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.degreePh.D.
refterms.dateFOA2020-11-05T16:15:53Z


Files in this item

Thumbnail
Name:
Yuan_2011_154268.pdf
Size:
2.069Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record